Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient setting.

Yoon, Nancy M; Cavaghan, Melissa K; Brunelle, Rocco L; Roach, Paris
Clinical therapeutics; 2009 Jul;31(7):1511-23. PMID: 19695400


Background: Exenatide is an antidiabctic agent currently indicated as adjunctive therapy with oral agents for the treatment of type 2 diabetes mellitus (T2DM). Limited published data exist on the off-label use of exenatide in conjunction with insulin in the treatment of T2DM.